instillations for pT1G3 bladder carcinoma. Multiparametric magnetic resonance (mpMRI) was carried out using a 1.5T system (Signa Excite, GE Healthcare) with a PI-RADS v2 score of 4 for diffusion-weighted imaging (DWI) in the right posteromedial peripheral zone at the midgland level ( Figure-1) . Thus, a 
instillations for pT1G3 bladder carcinoma. Multiparametric magnetic resonance (mpMRI) was carried out using a 1.5T system (Signa Excite, GE Healthcare) with a PI-RADS v2 score of 4 for diffusion-weighted imaging (DWI) in the right posteromedial peripheral zone at the midgland level ( Figure-1 ). Thus, a Patients with mycobacterial GP are mostly asymptomatic, with elevated PSA levels and indurated prostate at digital rectal examination, but because of its relative rarity, the MRI characteristics of infective GP caused by Mycobacterium tuberculosis or after intravesical BCG instillations have not been described extensively and only a few cases have been reported (1, 2) . GP is found in approximately 75% of patients after intravesical administration of BCG for superficial bladder cancer (3) . Despite the consistent ability of mpMRI to identify lesions suspicious for prostate cancer (PCa), there are other entities which can cause a false-positive result as GP, bacterial prostatitis or malacoplakia. GP chronic pattern is common, with low mean ADC value <1000, decreased signal on the ADC map images and isointense or decreased signal on high-b-value imaging (b>1200) (4) that could be differentiated by the intralesional ADC values, significantly lower in PCa, as suggested by Rais-Bahrami (5) . Recent studies also demonstrated an acute pattern (less than six months prior to the mpMRI) of GP lesions, with lower signal intensity on T2-weighted imaging (T2WI) (1), decreased signal on the ADC map images (3) and increased signal on high-b-value imaging (5) , that is indistinguishable from aggressive prostate cancer.
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